STAT+: UnitedHealth investor lawsuit moves forward on allegations it ‘manufactured earnings’ to hide declining profits — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- U.S. District Judge Jeffrey Bryan declined UnitedHealth's motion to dismiss, allowing CalPERS's lawsuit to proceed on allegations the insurer 'manufactured' $3.3 billion in 2024 earnings to conceal declining Medicare Advantage profits.
- CalPERS (California Public Employees' Retirement System) saw the bulk of its broader claims thrown out after the judge agreed with UnitedHealth that many cited statements were vague promotional 'puffery' investors wouldn't act on.
- The surviving core allegation targets UnitedHealth's alleged practice of making Medicare Advantage patients appear sicker on paper to draw higher payments from the government.
- Reporting cited in the lawsuit found UnitedHealth used home visits to add diagnoses to patient records with no follow-up care and pressured doctors via bonuses to do the same.
- UnitedHealth's statements that survived included claims that home visits kept members healthy and that clinicians made independent clinical decisions — the plaintiffs say those statements misled investors about the diagnosis practices.
Why it matters: The mixed ruling keeps the $3.3 billion earnings-manipulation theory alive against the nation's largest health insurer, meaning UnitedHealth must now defend in discovery its Medicare Advantage diagnosis practices and the specific executive statements CalPERS cited. For CalPERS and fellow shareholders, the partial survival opens a narrower but viable litigation path into internal documents that were previously off-limits.
Ask SkimNews
